BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6400475)

  • 1. Theory and practice of the use of expectorants reviewed from clinical aspects.
    Nagy G
    Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction].
    Löllgen H; Löllgen-Horres I; von Nieding G
    Fortschr Med; 1976 Aug; 94(24):1276-84. PubMed ID: 786833
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mucolytics and mucoregulators].
    Sternon J
    Rev Med Brux; 1987 Mar; 8(3):149-51. PubMed ID: 3589262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of mucociliary clearance by means of bronchofibroscopy].
    Blasi A; Olivieri D
    Arch Monaldi; 1982; 37(1-2):27-36. PubMed ID: 7187724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Round table. Relevant controls and usefulness of treatments modifying bronchial secretions (author's transl)].
    Bull Physiopathol Respir (Nancy); 1973; 9(2):417-71. PubMed ID: 4778961
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental studies on bronchial secretion. Therapeutical aspects of pathological bronchial secretion.
    Simonsson BG
    Scand J Respir Dis Suppl; 1974; 90():1-89. PubMed ID: 4618374
    [No Abstract]   [Full Text] [Related]  

  • 7. Cough and expectoration: general discussion.
    Eur J Respir Dis Suppl; 1980; 110():239-56. PubMed ID: 7011830
    [No Abstract]   [Full Text] [Related]  

  • 8. [Optimal use of expectorants (current trends)].
    Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
    Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of bronchosecretolytic disorders].
    Schmidt OP
    Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
    Primer G
    Ther Ggw; 1975 Aug; 114(8):1251-66. PubMed ID: 1108276
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
    Chalumeau M; Duijvestijn YC
    Cochrane Database Syst Rev; 2013 May; (5):CD003124. PubMed ID: 23728642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the mucoregulator ascoril for respiratory diseases].
    Shmeleva NM
    Ter Arkh; 2012; 84(10):86-90. PubMed ID: 23227508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
    Gramiccioni E; Pamparana F; Messa A
    Arch Monaldi Mal Torace; 1989; 44(4-6):791-3. PubMed ID: 2577796
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale of airway clearance.
    Clarke SW
    Eur Respir J Suppl; 1989 Jul; 7():599s-603s. PubMed ID: 2679608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
    Ertogan F
    Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
    [No Abstract]   [Full Text] [Related]  

  • 17. The physical properties of mucus and their clinical significance. Boehringer Ingelheim Workshop, Miami/Florida, March 1984.
    Bull Eur Physiopathol Respir; 1986; 22(2):207-12. PubMed ID: 2871879
    [No Abstract]   [Full Text] [Related]  

  • 18. [6 years of therapy with Bisolvon].
    Günthner W
    Ther Ggw; 1970 Jan; 109(1):34 passim. PubMed ID: 4910104
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mucolytic acitivity of bromhexine guaiacol combination in chronic bronchopneumopathy patients].
    Clini V; Guadagni L; Zennaro M; Fumagalli G
    G Clin Med; 1979 Jun; 60(6):475-89. PubMed ID: 381086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.